Quarterly report · Q2
7446.TEDINET S100TF5Q
Period2023-10-01 → 2024-03-31
Filed2024-05-15
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥16.6bn | 2023-10-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥35.1bn | 2022-10-01 → 2023-09-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥18.4bn | 2022-10-01 → 2023-03-31 | Cons. | Net sales |
| Operating income | ¥276m | 2023-10-01 → 2024-03-31 | Cons. | Operating income |
| Operating income | ¥532m | 2022-10-01 → 2023-03-31 | Cons. | Operating income |
| Ordinary income | ¥302m | 2023-10-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥808m | 2022-10-01 → 2023-09-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥552m | 2022-10-01 → 2023-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥314m | 2023-10-01 → 2024-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥552m | 2022-10-01 → 2023-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥211m | 2023-10-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥556m | 2022-10-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥367m | 2022-10-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥213m | 2023-10-01 → 2024-03-31 | Cons. | Profit loss |
| Net income | ¥373m | 2022-10-01 → 2023-03-31 | Cons. | Profit loss |
| Total assets | ¥19.8bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥18.9bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥17.8bn | at 2023-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥12.1bn | at 2024-03-31 | Cons. | Liabilities |
| Total liabilities | ¥11.7bn | at 2023-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥7.6bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥7.3bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥7.0bn | at 2023-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.2bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.2bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥2.2bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.1bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.1bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.3bn | at 2022-09-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥226m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.3bn | 2022-10-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥185m | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥54m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥335m | 2022-10-01 → 2023-09-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥288m | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥83m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥96m | 2022-10-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥46m | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥233.86 | 2023-10-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥174.52 | 2024-01-01 → 2024-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥617.29 | 2022-10-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥407.21 | 2022-10-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥204.9 | 2023-01-01 → 2023-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 38.2% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.0% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.8% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 16
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q2r_E02810-000Academia Life Science Sales Groupreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥1.2bn |
| jpcrp040300-q2r_E02810-000Academia Life Science Sales Groupreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥1.2bn |
| jpcrp040300-q2r_E02810-000Industry Sales Groupreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥8.3bn |
| jpcrp040300-q2r_E02810-000Industry Sales Groupreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥8.3bn |
| jpcrp040300-q2r_E02810-000Medical Sales Groupreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥7.1bn |
| jpcrp040300-q2r_E02810-000Medical Sales Groupreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥7.1bn |
| —segment total | revenue | 2023-10-01 → 2024-03-31 | ¥16.6bn |
| —segment total | revenue external | 2023-10-01 → 2024-03-31 | ¥16.6bn |
| jpcrp040300-q2r_E02810-000Academia Life Science Sales Groupreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥1.3bn |
| jpcrp040300-q2r_E02810-000Academia Life Science Sales Groupreportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥1.3bn |
| jpcrp040300-q2r_E02810-000Industry Sales Groupreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥9.1bn |
| jpcrp040300-q2r_E02810-000Industry Sales Groupreportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥9.1bn |
| jpcrp040300-q2r_E02810-000Medical Sales Groupreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥8.1bn |
| jpcrp040300-q2r_E02810-000Medical Sales Groupreportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥8.1bn |
| —segment total | revenue | 2022-10-01 → 2023-03-31 | ¥18.4bn |
| —segment total | revenue external | 2022-10-01 → 2023-03-31 | ¥18.4bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 505
| Item | Context | Value | Unit |
|---|---|---|---|
| Other ca | Prior1YearInstant | 314039000 | JPY |
| Other ca | CurrentQuarterInstant | 366807000 | JPY |
| Allowance for doubtful accounts ca | Prior1YearInstant | -60000 | JPY |
| Allowance for doubtful accounts ca | CurrentQuarterInstant | -1608000 | JPY |
| Current assets | Prior1YearInstant | 13618611000 | JPY |
| Current assets | CurrentQuarterInstant | 13927015000 | JPY |
| Buildings and structures net | Prior1YearInstant | 538514000 | JPY |
| Buildings and structures net | CurrentQuarterInstant | 561259000 | JPY |
| Land | Prior1YearInstant | 1495006000 | JPY |
| Land | CurrentQuarterInstant | 1495006000 | JPY |
| Lease assets net ppe | Prior1YearInstant | 158095000 | JPY |
| Lease assets net ppe | CurrentQuarterInstant | 152260000 | JPY |
| Other net ppe | Prior1YearInstant | 337944000 | JPY |
| Other net ppe | CurrentQuarterInstant | 338343000 | JPY |
| Property plant and equipment | Prior1YearInstant | 2529561000 | JPY |
| Property plant and equipment | CurrentQuarterInstant | 2546869000 | JPY |
| Lease assets ia | Prior1YearInstant | 15283000 | JPY |
| Lease assets ia | CurrentQuarterInstant | 17876000 | JPY |
| Software | Prior1YearInstant | 12637000 | JPY |
| Software | CurrentQuarterInstant | 366510000 | JPY |
| Software in progress | Prior1YearInstant | 419885000 | JPY |
| Software in progress | CurrentQuarterInstant | － | JPY |
| Intangible assets | Prior1YearInstant | 447806000 | JPY |
| Intangible assets | CurrentQuarterInstant | 384386000 | JPY |
| Investment securities | Prior1YearInstant | 1633932000 | JPY |
| Investment securities | CurrentQuarterInstant | 1978608000 | JPY |
| Lease investment assets ioa | Prior1YearInstant | 69413000 | JPY |
| Lease investment assets ioa | CurrentQuarterInstant | 355728000 | JPY |
| Other ioa | Prior1YearInstant | 643039000 | JPY |
| Other ioa | CurrentQuarterInstant | 587378000 | JPY |
| Allowance for doubtful accounts ioa by group | Prior1YearInstant | -21624000 | JPY |
| Allowance for doubtful accounts ioa by group | CurrentQuarterInstant | -21712000 | JPY |
| Investments and other assets | Prior1YearInstant | 2324760000 | JPY |
| Investments and other assets | CurrentQuarterInstant | 2900003000 | JPY |
| Noncurrent assets | Prior1YearInstant | 5302128000 | JPY |
| Noncurrent assets | CurrentQuarterInstant | 5831259000 | JPY |
| Assets | Prior1YearInstant | 18920740000 | JPY |
| Assets | CurrentQuarterInstant | 19758275000 | JPY |
| Notes and accounts payable trade | Prior1YearInstant | 9588734000 | JPY |
| Notes and accounts payable trade | CurrentQuarterInstant | 9724496000 | JPY |
| Electronically recorded obligations operating cl | Prior1YearInstant | 371971000 | JPY |
| Electronically recorded obligations operating cl | CurrentQuarterInstant | 377996000 | JPY |
| Short term loans payable | Prior1YearInstant | 233400000 | JPY |
| Short term loans payable | CurrentQuarterInstant | 282200000 | JPY |
| Current portion of long term loans payable | Prior1YearInstant | 14280000 | JPY |
| Current portion of long term loans payable | CurrentQuarterInstant | 14280000 | JPY |
| Lease obligations cl | Prior1YearInstant | 99378000 | JPY |
| Lease obligations cl | CurrentQuarterInstant | 141486000 | JPY |
| Accounts payable other | Prior1YearInstant | 158886000 | JPY |
| Accounts payable other | CurrentQuarterInstant | 28936000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |